{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:00:56Z","timestamp":1772802056840,"version":"3.50.1"},"publisher-location":"Cham","reference-count":42,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319754017","type":"print"},{"value":"9783319754024","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-75402-4_12","type":"book-chapter","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T13:23:42Z","timestamp":1525267422000},"page":"91-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gene Therapy Approaches to Treat the Neurodegeneration and Visual Failure in Neuronal Ceroid Lipofuscinoses"],"prefix":"10.1007","author":[{"given":"Sophia-Martha","family":"kleine Holthaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara E.","family":"Mole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin R.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.bbadis.2013.01.009","volume":"1832","author":"M Bond","year":"2013","unstructured":"Bond M, Holthaus SM, Tammen I et al (2013) Use of model organisms for the study of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 1832:1842\u20131865","journal-title":"Biochim Biophys Acta"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"9669","DOI":"10.1523\/JNEUROSCI.1635-16.2016","volume":"36","author":"ME Bosch","year":"2016","unstructured":"Bosch ME, Aldrich A, Fallet R et al (2016) Self-complementary AAV9 gene delivery partially corrects pathology associated with juvenile neuronal ceroid lipofuscinosis (CLN3). J Neurosci 36:9669\u20139682","journal-title":"J Neurosci"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","volume":"15","author":"MA Cabrera-Salazar","year":"2007","unstructured":"Cabrera-Salazar MA, Roskelley EM, Bu J et\u00a0al (2007) Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease. Mol Ther 15:1782\u20131788","journal-title":"Mol Ther"},{"key":"12_CR01","unstructured":"Cain J, Likhite S, Whitel K et al (2016) Testing saftey and efficacy of AAV9-CLN6 gene therapy in a mouse model of CLN6-Batten disease. Presented at the 15th International Conference on Neuronal Ceroid Lipofuscinoses, 5th-8th October 2016, Boston, Massachusetts, USA"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ymthe.2005.11.015","volume":"13","author":"CN Cearley","year":"2006","unstructured":"Cearley CN, Wolfe JH (2006) Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther 13:528\u2013537","journal-title":"Mol Ther"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/bjo.2006.091637","volume":"90","author":"J Collins","year":"2006","unstructured":"Collins J, Holder GE, Herbert H et al (2006) Batten disease: features to facilitate early diagnosis. Br J Ophthalmol 90:1119\u20131124","journal-title":"Br J Ophthalmol"},{"key":"12_CR6","first-page":"1331","volume":"15","author":"RG Crystal","year":"2004","unstructured":"Crystal RG, Sondhi D, Hackett NR et al (2004) Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis. Hum Gene Ther 15:1331\u20131354","journal-title":"Hum Gene Ther"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.nbd.2010.09.011","volume":"41","author":"SL Ding","year":"2011","unstructured":"Ding SL, Tecedor L, Stein CS et al (2011) A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures. Neurobiol Dis 41:237\u2013248","journal-title":"Neurobiol Dis"},{"issue":"1-2","key":"12_CR800","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ymgme.2016.07.011","volume":"119","author":"Michael Fietz","year":"2016","unstructured":"Fietz M, AlSayed M, Burke D et al (2016) Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis. Molecular Genetics and Metabolism 119(1-2):160\u2013167","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3","key":"12_CR801","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"Kevin D Foust","year":"2010","unstructured":"Foust KD, Xueyong Wang, McGovern VL et al (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nature Biotechnology 28(3):271\u2013274","journal-title":"Nature Biotechnology"},{"issue":"34","key":"12_CR802","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","volume":"33","author":"S. K. Garg","year":"2013","unstructured":"Garg SK, Lioy DT, Cheval H et al (2013) Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of rett syndrome. Journal of Neuroscience 33(34):13612\u201313620","journal-title":"Journal of Neuroscience"},{"key":"12_CR803","doi-asserted-by":"crossref","unstructured":"Geraets RD, Seung yon Koh, Hastings ML et al (2016) Moving towards effective therapeutic strategies for neuronal ceroid lipofuscinosis. Orphanet Journal of Rare Diseases 11(1)","DOI":"10.1186\/s13023-016-0414-2"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2004.03.005","volume":"16","author":"MA Griffey","year":"2004","unstructured":"Griffey MA, Bible E, Vogler C et al (2004) Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 16:360\u2013369","journal-title":"Neurobiol Dis"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ymthe.2005.04.018","volume":"12","author":"MA Griffey","year":"2005","unstructured":"Griffey MA, Macauley S, Ogilvie J et\u00a0al (2005) AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis. Mol Ther 12:413\u2013421","journal-title":"Mol Ther"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ymthe.2005.11.008","volume":"13","author":"MA Griffey","year":"2006","unstructured":"Griffey MA, Wozniak D, Wong M et al (2006) CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Mol Ther 13:538\u2013547","journal-title":"Mol Ther"},{"key":"12_CR804","unstructured":"Holthaus SM, Ribeiro J, Abelleira-Hervas L et al (2018) Prevention of photoreceptor cell loss in a Cln6nclf mouse model of Batten disease requires CLN6 gene transfer to bipolar cells. Molecular Therapy, in press"},{"issue":"1","key":"12_CR805","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2013.08.008","volume":"50","author":"Rakesh H. Jadav","year":"2014","unstructured":"Jadav RH, Sinha S, Yasha TC et al (2014) Clinical,electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes. Pediatric Neurology 50(1):85\u201395","journal-title":"Pediatric Neurology"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","volume":"1793","author":"A Jalanko","year":"2009","unstructured":"Jalanko A, Braulke T (2009) Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 1793:697\u2013709","journal-title":"Biochim Biophys Acta"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ymgme.2009.12.002","volume":"99","author":"B Jui-Yun Lua","year":"2010","unstructured":"Jui-Yun Lua B, Hub J, Hofmann SL (2010) Human recombinant palmitoyl protein thioesterase-1 (PPT1) for preclinical evaluation of enzyme replacement therapy for infantile neuronal ceroid lipofuscinosis. Mol Genet Meta 99:374\u2013378","journal-title":"Mol Genet Meta"},{"issue":"313","key":"12_CR806","doi-asserted-by":"publisher","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","volume":"7","author":"Martin L. Katz","year":"2015","unstructured":"Katz ML, Tecedor L, Yonghong Chen et al (2015) AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease. Science Translational Medicine 7(313):313ra180\u2013313ra180","journal-title":"Science Translational Medicine"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.bbadis.2013.01.019","volume":"1832","author":"K Kollmann","year":"2013","unstructured":"Kollmann K, Uusi-Rauva K, Scifo E et al (2013) Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. Biochim Biophys Acta 1832:1866\u20131881","journal-title":"Biochim Biophys Acta"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.bi.61.070192.001515","volume":"61","author":"S Kornfeld","year":"1992","unstructured":"Kornfeld S (1992) Structure and function of the mannose 6-phosphate\/insulinlike growth factor II receptors. Annu Rev Biochem 61:307\u2013330","journal-title":"Annu Rev Biochem"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/humu.21624","volume":"33","author":"M Kousi","year":"2011","unstructured":"Kousi M, Lehesjoki AE, Mole SE (2011) Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat 33:42\u201363","journal-title":"Hum Mutat"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.23545","volume":"71","author":"SL Macauley","year":"2012","unstructured":"Macauley SL, Roberts MS, Wong AM et al (2012) Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis. An Neurol 71:797\u2013804","journal-title":"An Neurol"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0014-5793(03)01274-2","volume":"555","author":"Q Mao","year":"2003","unstructured":"Mao Q, Xia H, Davidson BL (2003) Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease. FEBS Lett 555:351\u2013357","journal-title":"FEBS Lett"},{"issue":"3","key":"12_CR807","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"Kathrin Meyer","year":"2015","unstructured":"Meyer K, Ferraiuolo L, Schmelzer L et al (2014) Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: A dose\u2013response study in mice and nonhuman primates. Molecular Therapy 23(3): 477\u2013487","journal-title":"Molecular Therapy"},{"key":"12_CR808","unstructured":"Mitchell NL, Barrell GK, Russell KN al (2016) Gene transfer can prevent stereotypical disease development in ovine CLN5 and CLN6 models of NCL. Presented at the 15th International Conference on Neuronal Ceroid Lipofuscinoses, 5th-8th October 2016, Boston, Massachusetts, USA"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","volume":"6","author":"SE Mole","year":"2005","unstructured":"Mole SE, Williams RE, Goebel HH (2005) Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6:107\u2013126","journal-title":"Neurogenetics"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1126\/science.169.3941.141","volume":"169","author":"EF Neufeld","year":"1970","unstructured":"Neufeld EF, Fratantoni JC (1970) Inborn errors of mucopolysaccharide metabolism: faulty degradative mechanisms are implicated in this group of human diseases. Science 169:141\u2013146","journal-title":"Science"},{"issue":"10","key":"12_CR809","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.bbadis.2015.04.026","volume":"1852","author":"Nicole J. Neverman","year":"2015","unstructured":"Neverman NJ, Best HL, Hofmann SL et al (2015) Experimental therapies in the neuronal ceroid lipofuscinoses. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852(10):2292\u20132300","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","volume":"26","author":"MA Passini","year":"2006","unstructured":"Passini MA, Dodge JC, Bu J et\u00a0al (2006) Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis. J Neurosci 26:1334\u20131342","journal-title":"J Neurosci"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/gt.2011.118","volume":"18","author":"LS Pike","year":"2011","unstructured":"Pike LS, Tannous BA, Deliolanis NC et al (2011) Imaging gene delivery in a mouse model of congenital neuronal ceroid lipofuscinosis. Gene Ther 18:1173\u20131178","journal-title":"Gene Ther"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","volume":"1832","author":"A Schulz","year":"2013","unstructured":"Schulz A, Kohlsch\u00fctter A, Mink J et\u00a0al (2013) NCL diseases - clinical perspectives. Biochim Biophys Acta 1832:1801\u20131806","journal-title":"Biochim Biophys Acta"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2353\/ajpath.2010.091267","volume":"177","author":"Z Shevtsova","year":"2010","unstructured":"Shevtsova Z, Garrido M, Weishaupt J et\u00a0al (2010) CNS-expressed cathepsin D prevents lymphopenia in a murine model of congenital neuronal ceroid lipofuscinosis. Am J Pathol 177:271\u2013279","journal-title":"Am J Pathol"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/sj.mt.6300049","volume":"15","author":"D Sondhi","year":"2007","unstructured":"Sondhi D, Hackett NR, Peterson DA et al (2007) Molecular therapy\u00a0\u2013 enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector. Mol Ther 15:481\u2013491","journal-title":"Mol Ther"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1089\/hgtb.2012.120","volume":"23","author":"D Sondhi","year":"2012","unstructured":"Sondhi D, Johnson L, Purpura K et al (2012) Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis. Hum Gene Ther Meth 23:324\u2013335","journal-title":"Hum Gene Ther Meth"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/hum.2012.253","volume":"25","author":"D Sondhi","year":"2014","unstructured":"Sondhi D, Scott EC, Chen A et al (2014) Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3Gene. Hum Gene Ther 25:223\u2013239","journal-title":"Hum Gene Ther"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","volume":"82","author":"The International Batten Disease Consortium","year":"1995","unstructured":"The International Batten Disease Consortium (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell 82:949\u2013957","journal-title":"Cell"},{"key":"12_CR28","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","volume":"1832","author":"V Warrier","year":"2013","unstructured":"Warrier V, Vieira M, Mole SE (2013) Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses. Biochim Biophys Acta 1832:1827\u20131830","journal-title":"Biochim Biophys Acta"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","volume":"79","author":"RE Williams","year":"2012","unstructured":"Williams RE, Mole SE (2012) New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 79:183\u2013191","journal-title":"Neurology"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bbadis.2006.07.001","volume":"1762","author":"RE Williams","year":"2006","unstructured":"Williams RE, Aberg L, Autti T et al (2006) Diagnosis of the neuronal ceroid lipofuscinoses: an update. Biochim Biophys Acta 1762:865\u2013872","journal-title":"Biochim Biophys Acta"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/hum.2008.022","volume":"19","author":"S Worgall","year":"2008","unstructured":"Worgall S, Sondhi D, Hackett NR et al (2008) Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum Gene Ther 19:463\u2013474","journal-title":"Hum Gene Ther"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-75402-4_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T09:27:09Z","timestamp":1571304429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-75402-4_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319754017","9783319754024"],"references-count":42,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-75402-4_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}